SBFM — SUNSHINE BIOPHARMA INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $35.4M | -5.2% | -$6.2M | — | -21.6% | 32.8% | -13.0% | — | — | — | — |
Revenue YoY trend Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -39.00 | — | -39.00 | -39.00 | 1 | — |
| Dec 2027 | -8.00 | — | -8.00 | -8.00 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 14 SEC-registered investment managers reported holding SBFM (SUNSHINE BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $121.73K across 157.70K shares. That is +292.6% by share count (+45.44K shares) versus the previous quarter, while reported value moved +44.5%. Ownership is concentrated: the five largest holders account for 98.8% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 7 opened new positions, 3 added to existing stakes, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of SUNSHINE BIOPHARMA INC (SBFM) include ARMISTICE CAPITAL, LLC, Altium Capital Management LLC, Renaissance Technologies, ranked by reported 13F value among the 41 institutional holders on this page.
SBFM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 14 | 157.70K | $121.73K | +292.6% |
| Q2 2026 | 9 | 15.53K | $32.62K | -96.6% |
| Q1 2026 | 12 | 122.21K | $127.09K | -6.9% |
| Q4 2025 | 13 | 115.00K | $141.68K | -13.4% |
| Q3 2025 | 13 | 181.42K | $270.32K | +11.2% |
| Q2 2025 | 12 | 129.99K | $187.18K | -62.4% |
| Q1 2025 | 11 | 79.43K | $151.71K | +213.6% |
| Q4 2024 | 12 | 20.58K | $61.75K | -77.8% |
Over the 8 quarters shown, institutional share counts increased 666% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+213.6%).
Top Institutional Holders (Q3 2026) — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 60.31K | $46.62K | 0.00% | Add | |
| 34.72K | $26.83K | 0.00% | New | |
| 22.22K | $17.00K | 0.00% | New | |
| 20.16K | $15.59K | 0.00% | New | |
| 18.40K | $14.22K | 0.00% | New | |
| 1.20K | $928 | 0.00% | New | |
| 385 | $298 | 0.00% | Hold | |
| 213 | $165 | 0.00% | Add | |
| 50 | $39 | 0.00% | Add | |
| 39 | $30 | 0.00% | New | |
| 8 | $6 | 0.00% | New | |
| 5 | $4 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.97K | $31.45K | 0.00% | New | |
| 385 | $808 | 0.00% | Reduce | |
| 162 | $340 | 0.00% | Reduce | |
| 5 | $10 | 0.00% | Reduce | |
| 2 | $4 | 0.00% | Hold | |
| 1 | $2 | 0.00% | New | |
| 1 | $2 | 0.00% | Hold | |
| 1 | $2 | 0.00% | New | |
| 1 | $2 | 0.00% | Hold |
Q1 2026 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 46.25K | $48.10K | 0.00% | Reduce | |
| 23.48K | $24.42K | 0.00% | New | |
| 21.46K | $22.32K | 0.00% | Add | |
| 14.63K | $15.22K | 0.00% | Hold | |
| 13.44K | $13.97K | 0.00% | New | |
| 1.83K | $1.91K | 0.00% | Reduce | |
| 1.10K | $1.15K | 0.00% | Reduce | |
| 9 | $9 | 0.00% | Reduce | |
| 2 | $2 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q4 2025 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 53.93K | $66.33K | 0.00% | Reduce | |
| 23.39K | $29.00K | 0.00% | New | |
| 16.16K | $19.87K | 0.00% | New | |
| 14.63K | $18.00K | 0.00% | Add | |
| 4.85K | $5.96K | 0.00% | Hold | |
| 1.87K | $2.30K | 0.00% | Add | |
| 152 | $186 | 0.00% | Hold | |
| 10 | $12 | 0.00% | Hold | |
| 5 | $6 | 0.00% | Hold | |
| 1 | $2 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q3 2025 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 78.09K | $116.35K | 0.00% | Add | |
| 55.70K | $82.99K | 0.00% | Add | |
| 21.40K | $31.89K | 0.00% | New | |
| 17.18K | $25.59K | 0.00% | New | |
| 4.85K | $7.23K | 0.00% | Reduce | |
| 3.83K | $5.71K | 0.00% | Hold | |
| 206 | $307 | 0.00% | Hold | |
| 152 | $225 | 0.00% | Hold | |
| 10 | $15 | 0.00% | Hold | |
| 5 | $7 | 0.00% | Hold | |
| 1 | $2 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q2 2025 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 63.43K | $91.34K | 0.00% | New | |
| 54.09K | $77.89K | 0.00% | New | |
| 6.69K | $9.64K | 0.00% | Add | |
| 3.83K | $5.52K | 0.00% | Hold | |
| 1.56K | $2.24K | 0.01% | New | |
| 206 | $297 | 0.00% | Reduce | |
| 152 | $218 | 0.00% | Add | |
| 10 | $14 | 0.00% | Hold | |
| 5 | $7 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
New Positions (Q3 2026)
- UBS Group AG 34.72K sh · $26.83K
- Virtu Financial LLC 22.22K sh · $17.00K
- XTX Topco Ltd 20.16K sh · $15.59K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 18.40K sh · $14.22K
- Pinnacle Financial Group, Inc. 1.20K sh · $928
- Robinhood Markets, Inc. 39 sh · $30
- JPMorgan Chase & Co 8 sh · $6
Fully Exited (vs previous quarter)
- OSAIC HOLDINGS, INC. sold 2 sh · $4
- Farther Finance Advisors, LLC sold 1 sh · $2
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 60.31K | 14.97K | — | — | — | — | — | — | — | 27.86K | 87.61K | — | — | — | — | — | — | — | — |
| UBS Group AG | 34.72K | — | 1.10K | 1.87K | 206 | 206 | 19.89K | 868 | — | — | — | 2.20K | — | 1 | 2.41K | 7.21K | 1 | 1 | 2.43K |
| Virtu Financial LLC | 22.22K | — | — | 23.39K | — | — | — | — | — | — | — | 23.86K | — | — | — | — | — | — | — |
| XTX Topco Ltd | 20.16K | — | 21.46K | 16.16K | — | — | — | — | — | 44.01K | 53.72K | 17.50K | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 18.40K | — | — | — | — | — | — | — | — | 76.97K | — | — | — | — | — | — | — | — | — |
| Pinnacle Financial Group, Inc. | 1.20K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 385 | 385 | 14.63K | 14.63K | 3.83K | 3.83K | 3.83K | 7.64K | 1 | 1.00K | — | — | 26 | 26 | 26 | — | — | 6.87K | — |
| SBI Securities Co., Ltd. | 213 | 162 | 1.83K | 4.85K | 4.85K | 6.69K | 5.22K | 709 | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 50 | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Robinhood Markets, Inc. | 39 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 8 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NATIONAL BANK OF CANADA /FI/ | 5 | 5 | 9 | 10 | 10 | 10 | 10 | 7 | 7 | 65 | — | 6.04K | 6.04K | — | — | — | — | — | — |
| TD Waterhouse Canada Inc. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | — | — | — | — | — | — | — | — | — | — |
| Strive Financial Group ,LLC | 1 | 1 | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | — | — | — | — | — | 2.13M | 974.00K | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | 55.70K | 54.09K | — | — | — | — | 4.61M | 66.60K | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | 46.25K | 53.93K | 78.09K | 63.43K | — | — | — | — | 550.51K | 185.25K | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | — | 5 | 5 | 5 | 5 | 5 | 34.48K | 100 | 10.00K | 10.00K | — | — | — | 13.87K | 17.02K | 3.33K | — |
| Altium Capital Management LLC | — | — | — | — | — | — | 50.47K | — | — | — | — | — | — | — | — | — | — | — | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | — | — | — | — | — | — | — | — | — | — | 286.10K | 286.10K | 286.10K | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SBFM?
As of 2026-Q3, 14 institutional funds reported holding SBFM (SUNSHINE BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $121.73K.
How many shares of SBFM do institutions own?
13F filers reported 157.70K shares of SBFM, worth $121.73K in aggregate at the end of 2026-Q3.
Is institutional ownership of SBFM rising or falling?
Share counts moved +292.6% versus the prior quarter — accumulation.
Who are the top institutional holders of SBFM?
The largest 13F holders are ARMISTICE CAPITAL, LLC, Altium Capital Management LLC, Renaissance Technologies, Citadel Advisors, JANE STREET GROUP, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of SUNSHINE BIOPHARMA INC?
The major shareholders of SUNSHINE BIOPHARMA INC (SBFM) by reported 13F value are ARMISTICE CAPITAL, LLC, Altium Capital Management LLC, Renaissance Technologies, Citadel Advisors, JANE STREET GROUP, LLC, among 41 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.